GLYN Edwards MBE, has been appointed a non-executive director of OxSonics.

The Oxford-based company is a world-leader in the development of ultrasound-based drug delivery systems.

It was established to develop a new generation of ultrasound-based medical devices invented at Oxford University’s Institute of Biomedical Engineering.

Mr Edwards was made an MBE for his services to the biotechnology industry in 2006.

Dr. Colin Story, chief executive officer of OxSonics, said: “Glyn Edwards brings over four decades of leadership expertise in oncology and other therapeutic areas.”